Fatty liver disease: Should you be tested?
Even a little exercise linked with lower stroke risk in people with afib
Testosterone therapy without evidence of deficiency may boost heart risk
Weight-loss drug may lower risk of heart attacks and infections
Migraine: How it's diagnosed and what that means
Tricep workouts you can do at home
Mindfulness practices to reduce stress and improve focus
Antihistamines may not offer meaningful relief from eczema symptoms
Overweight and taking blood pressure medications: Study finds it's a trend that's working
FDA approves first mRNA-based flu vaccine
William Renthal, MD, PhD
Contributor
William Renthal, MD, PhD, is the director of molecular genetics at the John R. Graham Headache Center. Dr. Renthal completed his MD, PhD and neurology residency at the University of Texas Southwestern Medical Center, and joined Brigham and Women’s Hospital for his final year of residency and postgraduate training in headache medicine.
He is board certified in neurology and provides patients with comprehensive headache care including advanced diagnostics and personalized treatment plans, which may include behavioral/complementary therapy, medication and/or procedures (e.g. nerve blocks, Botox).
In addition to clinical care, Dr. Renthal conducts neuroscience and genetics research at Harvard Medical School where he is interested in the genetic and epigenetic mechanisms underlying migraine. He has published over 30 peer-reviewed articles and book chapters on his research.
Posts by William Renthal, MD, PhD
Fatty liver disease: Should you be tested?
Even a little exercise linked with lower stroke risk in people with afib
Testosterone therapy without evidence of deficiency may boost heart risk
Weight-loss drug may lower risk of heart attacks and infections
Migraine: How it's diagnosed and what that means
Tricep workouts you can do at home
Mindfulness practices to reduce stress and improve focus
Antihistamines may not offer meaningful relief from eczema symptoms
Overweight and taking blood pressure medications: Study finds it's a trend that's working
FDA approves first mRNA-based flu vaccine
